FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to psychiatry, and refers to laboratory diagnostics of inductive negative symptoms in schizophrenic patients. For this purpose, content of serum glutamate in schizophrenia patient's blood, and with concentration above 48.6 nmol/ml shows inductive negative symptoms.
EFFECT: method provides higher diagnostic accuracy in given group of patients.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LABORATORY DIAGNOSTIC TECHNIQUE FOR SCHIZOTYPAL DISORDER | 2014 |
|
RU2569741C1 |
| LABORATORY DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR GUIDING POSITIVE AND NEGATIVE SEMIOLOGY IN SCHIZOPHRENIC PATIENTS | 2011 |
|
RU2482486C1 |
| LABORATORY DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR ENDOGENOUS PSYCHOSIS | 2013 |
|
RU2522236C1 |
| DIAGNOSTIC TECHNIQUE FOR ASTHENIC SYNDROME IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2709105C1 |
| METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| LABORATORY METHOD OF DIAGNOSING BIPOLAR AFFECTIVE DISORDER | 2013 |
|
RU2558056C2 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN DEPRESSIVE EPISODE | 2013 |
|
RU2530635C1 |
| METHOD FOR PREDICTION OF THE PROBABILITY OF AN UNFAVORABLE OUTCOME IN RELATION TO THE SOCIAL POSTPSYCHOTIC FUNCTIONING OF THE PATIENTS WITH ENDOGENOUS PSYCHIC DISEASES | 2018 |
|
RU2706216C1 |
| METHOD FOR PREDICTION OF RISK OF DELAYED DYSKINESIA ACCOMPANYING NEUROLEPTIC THERAPY IN SCHIZOPHRENICS | 2010 |
|
RU2447832C1 |
